These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5841666)

  • 21. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.
    Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tolazamide as an antidiabetic].
    Witte JJ
    Ned Tijdschr Geneeskd; 1967 Feb; 111(5):215-8. PubMed ID: 5342766
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulfonylurea effects on target tissues for insulin.
    McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
    Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Repeated halothane-anaesthetics for laryngotracheal stenoses. How great is the risk of liver damage?].
    Berendes S; Bonhoeffer K; Rose KG
    HNO; 1982 Aug; 30(8):307-10. PubMed ID: 7118604
    [No Abstract]   [Full Text] [Related]  

  • 25. Tolazamide proves valuable as oral hypoglycemic agent.
    Delgado JN; Cosgrove FP; Isaacson EI
    Tex Med; 1966 Aug; 62(8):91-2. PubMed ID: 5946342
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetes and the liver.
    Padmanabhan M; Mohan V
    J Assoc Physicians India; 2000 Aug; 48(8):824-8. PubMed ID: 11273479
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes drug Rezulin: take it, but take precautions.
    Health News; 1999 May; 5(6):7. PubMed ID: 10546576
    [No Abstract]   [Full Text] [Related]  

  • 28. [Early liver damage caused by alcohol].
    Garcá Vigil JL; Aguirre García J; Pérez Muñoz HA; López Bárcena JJ; Lifshitz Guinzberg A
    Rev Gastroenterol Mex; 1980; 45(4):167-74. PubMed ID: 7466143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the tolerance of the liver for 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (mesterolone)].
    Pohle HD
    Arzneimittelforschung; 1966 Apr; 16(4):473-4. PubMed ID: 6014253
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical applications of anabolic steroids and their mechanism of action--effect on liver function, especially on the BSP test].
    Yoshitoshi Y; Oda T; Suzuki H; Naito C; Yamanaka M
    Saishin Igaku; 1966 May; 21(5):1059-71. PubMed ID: 5966054
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of long-term Antigest administration on hepatic functions].
    Sochman J; Stĕrba R
    Cesk Gynekol; 1967 Apr; 32(3):205-7. PubMed ID: 6082991
    [No Abstract]   [Full Text] [Related]  

  • 32. Liver damage in obese patients.
    Del Gaudio A; Boschi L; Del Gaudio GA; Mastrangelo L; Munari D
    Obes Surg; 2002 Dec; 12(6):802-4. PubMed ID: 12568185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of liver function during erythromycin estolate treatment.
    Grönroos JA; Saarimaa HA; Kalliomäki JL
    Curr Ther Res Clin Exp; 1967 Dec; 9(12):589-94. PubMed ID: 4965452
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
    Akbri MZ; Fatima N; ul Haque E; Shiekh AS; Bhatti MS
    J Ayub Med Coll Abbottabad; 2001; 13(2):5-10. PubMed ID: 11732224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic function and methoxyflurane. Studies with Bufano's aminoacidemic curves].
    Zolfanelli R; Consorti P; Biagi G
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):517-24. PubMed ID: 5621905
    [No Abstract]   [Full Text] [Related]  

  • 36. Pioglitazone (Actos).
    Med Lett Drugs Ther; 1999 Nov; 41(1066):112. PubMed ID: 10987011
    [No Abstract]   [Full Text] [Related]  

  • 37. [1st clinical experience with a new oral hypoglycemic agent: tolazamide, 1-(hexahydro-1-azepinyl)-3-p-tolysulfonylurea].
    LUCCHI R; ROBBA L
    Gazz Int Med Chir; 1962 Dec; 66():2599-609. PubMed ID: 13931428
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypersensitization to protamine-containing insulin].
    Räsänen L; Tuomi ML; Lahtela J; Knip M
    Duodecim; 1995; 111(10):914-8. PubMed ID: 9081826
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatic function and estrogenic therapy (TACE) in the climacteric].
    Cazzola D
    Riv Ostet Ginecol; 1968 Feb; 23(2):122-38. PubMed ID: 5736530
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in hepatic biology and hyperpotassemia caused by heparin].
    Ponz E; Fernández-Solá J; Navarro M; Ingelmo M
    Med Clin (Barc); 1986 Dec; 87(19):823-4. PubMed ID: 3821243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.